Amanote Research
Register
Sign In
Pcn256 - Indication-Specific Pricing in Oncology: How Will U.S. Payers Determine Value Amid This Growing Trend?
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.338
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
R. Moore
C. Lewis
Publisher
Elsevier BV
Related search
Will U.S. Payers Champion Biosimilars?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcp1 - Comparison of the German Mixed Price Model and Indication-Specific Pricing for Multi-Indication Products in Oncology
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Drug Pricing and Value in Oncology
Oncologist
Cancer Research
Medicine
Oncology
Pcp6 - How to Introduce Multi-Indication Based Pricing in Finland?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
How the Climate Will Change in This Century?
Hungarian Geographical Bulletin
Planning
Earth
Planetary Sciences
Development
Geography
This Is One Element That Will Change How You Work.
Chemical and Engineering News
Chemical Engineering
Massey Will Leave NSF Amid Controversy Over Its Future
Nature
Multidisciplinary
Biosimilars: How Can Payers Get Long-Term Savings?
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
A Comparative Study of Food Security in Africa Amid Growing Population
International Journal of Scientific and Research Publications (IJSRP)
